Blood Pressure in Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Overview

Journal Kidney Int

Publisher Elsevier

Specialty Nephrology

Date 2019 Apr 24

PMID 31010478

Citations 27

Authors

Alfred K Cheung

Tara I Chang

William C Cushman

Susan L Furth

Joachim H Ix

Roberto Pecoits-Filho

Vlado Perkovic

Mark J Sarnak

Sheldon W Tobe

Charles R V Tomson

Michael Cheung

David C Wheeler

Wolfgang C Winkelmayer

Johannes F E Mann

Affiliations

Soon will be listed here.

Abstract

In September 2017, KDIGO (Kidney Disease: Improving Global Outcomes) convened a Controversies Conference titled Blood Pressure in Chronic Kidney Disease (CKD). The purpose of the meeting was to consider which recommendations from the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD should be reevaluated based on new evidence from clinical trials. Participants included a multidisciplinary panel of clinical and scientific experts. Discussions focused on the optimal means for measuring blood pressure (BP) as well as managing BP in CKD patients. Consistent with the 2012 Guideline, the conference did not address BP management in patients on maintenance dialysis.

Citing Articles

Impact of hyperkalaemia on renin-angiotensin-aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation.

Logan Ellis H, Al-Agil M, Kelly P, Teo J, Sharpe C, Whyte M Clin Exp Med. 2024; 25(1):16.

PMID: 39708241 PMC: 11663150. DOI: 10.1007/s10238-024-01531-9.

Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study.

Riccio E, DErcole A, Sannino A, Hamzeh S, De Marco O, Capuano I J Nephrol. 2024; 37(4):1077-1084.

PMID: 38319545 DOI: 10.1007/s40620-024-01897-9.

Blood pressure management and long-term outcomes in kidney transplantation: a holistic view over a 35-year period.

Tchatat Wangueu L, de Freminville J, Gatault P, Buchler M, Longuet H, Bejan-Angoulvant T J Nephrol. 2023; 36(7):1931-1943.

PMID: 37548826 DOI: 10.1007/s40620-023-01706-9.

Renin-angiotensin-aldosterone pathway modulators in chronic kidney disease: A comparative review.

Alshahrani S Front Pharmacol. 2023; 14:1101068.

PMID: 36860293 PMC: 9970101. DOI: 10.3389/fphar.2023.1101068.

Chinese Clinical Practice Guideline for the Management of "CKD-PeriDialysis"-the Periods Prior to and in the Early-Stage of Initial Dialysis.

Kidney Int Rep. 2022; 7(12 Suppl):S531-S558.

PMID: 36567827 PMC: 9782818. DOI: 10.1016/j.ekir.2022.10.001.